276 related articles for article (PubMed ID: 17671288)
1. A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression.
Frye MA; Grunze H; Suppes T; McElroy SL; Keck PE; Walden J; Leverich GS; Altshuler LL; Nakelsky S; Hwang S; Mintz J; Post RM
Am J Psychiatry; 2007 Aug; 164(8):1242-9. PubMed ID: 17671288
[TBL] [Abstract][Full Text] [Related]
2. Sodium oxybate improves excessive daytime sleepiness in narcolepsy.
Black J; Houghton WC
Sleep; 2006 Jul; 29(7):939-46. PubMed ID: 16895262
[TBL] [Abstract][Full Text] [Related]
3. Modafinil augmentation of antidepressant treatment in depression.
Menza MA; Kaufman KR; Castellanos A
J Clin Psychiatry; 2000 May; 61(5):378-81. PubMed ID: 10847314
[TBL] [Abstract][Full Text] [Related]
4. Placebo and modafinil effect on sleepiness in obstructive sleep apnea.
Bittencourt LR; Lucchesi LM; Rueda AD; Garbuio SA; Palombini LO; Guilleminault C; Tufik S
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):552-9. PubMed ID: 18053628
[TBL] [Abstract][Full Text] [Related]
5. Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder: a randomized, multicenter, double-blind, placebo-controlled, proof-of-concept study.
Calabrese JR; Ketter TA; Youakim JM; Tiller JM; Yang R; Frye MA
J Clin Psychiatry; 2010 Oct; 71(10):1363-70. PubMed ID: 20673554
[TBL] [Abstract][Full Text] [Related]
6. A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression.
Krystal AD; Harsh JR; Yang R; Rippon GA; Lankford DA
J Clin Psychiatry; 2010 Jan; 71(1):32-40. PubMed ID: 20051221
[TBL] [Abstract][Full Text] [Related]
7. Adjunctive use of modafinil in bipolar patients: just another stimulant or not?
Shelton RC; Reddy R
Curr Psychiatry Rep; 2008 Dec; 10(6):520-4. PubMed ID: 18980736
[TBL] [Abstract][Full Text] [Related]
8. A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness.
Fava M; Thase ME; DeBattista C
J Clin Psychiatry; 2005 Jan; 66(1):85-93. PubMed ID: 15669893
[TBL] [Abstract][Full Text] [Related]
9. Coadministration of modafinil and a selective serotonin reuptake inhibitor from the initiation of treatment of major depressive disorder with fatigue and sleepiness: a double-blind, placebo-controlled study.
Dunlop BW; Crits-Christoph P; Evans DL; Hirschowitz J; Solvason HB; Rickels K; Garlow SJ; Gallop RJ; Ninan PT
J Clin Psychopharmacol; 2007 Dec; 27(6):614-9. PubMed ID: 18004129
[TBL] [Abstract][Full Text] [Related]
10. Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study.
DeBattista C; Doghramji K; Menza MA; Rosenthal MH; Fieve RR;
J Clin Psychiatry; 2003 Sep; 64(9):1057-64. PubMed ID: 14628981
[TBL] [Abstract][Full Text] [Related]
11. Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials.
Goss AJ; Kaser M; Costafreda SG; Sahakian BJ; Fu CH
J Clin Psychiatry; 2013 Nov; 74(11):1101-7. PubMed ID: 24330897
[TBL] [Abstract][Full Text] [Related]
12. A prospective trial of modafinil as an adjunctive treatment of major depression.
DeBattista C; Lembke A; Solvason HB; Ghebremichael R; Poirier J
J Clin Psychopharmacol; 2004 Feb; 24(1):87-90. PubMed ID: 14709953
[TBL] [Abstract][Full Text] [Related]
13. Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness.
Fava M; Thase ME; DeBattista C; Doghramji K; Arora S; Hughes RJ
Ann Clin Psychiatry; 2007; 19(3):153-9. PubMed ID: 17729016
[TBL] [Abstract][Full Text] [Related]
14. An open-label study of adjunctive modafinil in patients with sedation related to serotonergic antidepressant therapy.
Schwartz TL; Azhar N; Cole K; Hopkins G; Nihalani N; Simionescu M; Husain J; Jones N
J Clin Psychiatry; 2004 Sep; 65(9):1223-7. PubMed ID: 15367049
[TBL] [Abstract][Full Text] [Related]
15. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy.
Broughton RJ; Fleming JA; George CF; Hill JD; Kryger MH; Moldofsky H; Montplaisir JY; Morehouse RL; Moscovitch A; Murphy WF
Neurology; 1997 Aug; 49(2):444-51. PubMed ID: 9270575
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic evaluation of armodafinil for the treatment of bipolar depression.
Niemegeers P; Maudens KE; Morrens M; Patteet L; Joos L; Neels H; Sabbe BG
Expert Opin Drug Metab Toxicol; 2012 Sep; 8(9):1189-97. PubMed ID: 22803602
[TBL] [Abstract][Full Text] [Related]
17. Modafinil treatment for fatigue in HIV/AIDS: a randomized placebo-controlled study.
Rabkin JG; McElhiney MC; Rabkin R; McGrath PJ
J Clin Psychiatry; 2010 Jun; 71(6):707-15. PubMed ID: 20492840
[TBL] [Abstract][Full Text] [Related]
18. Initiating treatment with modafinil for control of excessive daytime sleepiness in patients switching from methylphenidate: an open-label safety study assessing three strategies.
Thorpy MJ; Schwartz JR; Kovacevic-Ristanovic R; Hayduk R
Psychopharmacology (Berl); 2003 Jun; 167(4):380-5. PubMed ID: 12709775
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of adjunctive armodafinil in adults with major depressive episodes associated with bipolar I disorder: a randomized, double-blind, placebo-controlled, multicenter trial.
Calabrese JR; Frye MA; Yang R; Ketter TA;
J Clin Psychiatry; 2014 Oct; 75(10):1054-61. PubMed ID: 25099397
[TBL] [Abstract][Full Text] [Related]
20. Modafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: a 12-week, open-label, extension study.
Thase ME; Fava M; DeBattista C; Arora S; Hughes RJ
CNS Spectr; 2006 Feb; 11(2):93-102. PubMed ID: 16520686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
